(Q53465653)
Statements
Prospective assessment of discontinuation and reinitiation of erlotinib or gefitinib in patients with acquired resistance to erlotinib or gefitinib followed by the addition of everolimus. (English)
William Pao
1 reference
Gregory J Riely
Binsheng Zhao
Tim Akhurst
Daniel T Milton
Erin Moore
Leslie Tyson
Naiyer A Rizvi
Lawrence H Schwartz
Vincent A Miller
1 September 2007
13
17
5150-5155